PubMed

Association between carotid diameter and the advanced glycation end product N-epsilon-carboxymethyllysine (CML).

Baumann M, Richart T, Sollinger D, Pelisek J, Roos M, Kouznetsova T, Eckstein HH, Heemann U, Staessen JA.

Cardiovasc Diabetol. 2009 Aug 6;8:45.PMID: 19660101 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults.

Semba RD, Najjar SS, Sun K, Lakatta EG, Ferrucci L.

Am J Hypertens. 2009 Jan;22(1):74-9. Epub 2008 Nov 20.PMID: 19023277 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end-products and arterial stiffness in hypertension.

McNulty M, Mahmud A, Feely J.

Am J Hypertens. 2007 Mar;20(3):242-7.PMID: 17324733 [PubMed - indexed for MEDLINE]Related articles

High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes.

Yoshida N, Okumura K, Aso Y.

Metabolism. 2005 Mar;54(3):345-50.PMID: 15736112 [PubMed - indexed for MEDLINE]Related articles

Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema.

Boehm BO, Schilling S, Rosinger S, Lang GE, Lang GK, Kientsch-Engel R, Stahl P.

Diabetologia. 2004 Aug;47(8):1376-9. Epub 2004 Jul 17.PMID: 15258735 [PubMed - indexed for MEDLINE]Related articles

The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.

Busch M, Franke S, Wolf G, Brandstädt A, Ott U, Gerth J, Hunsicker LG, Stein G; Collaborative Study Group.

Am J Kidney Dis. 2006 Oct;48(4):571-9.PMID: 16997053 [PubMed - indexed for MEDLINE]Related articles

Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.

Suliman ME, Stenvinkel P, Jogestrand T, Maruyama Y, Qureshi AR, Bárány P, Heimbürger O, Lindholm B.

Clin Nephrol. 2006 Dec;66(6):418-25.PMID: 17176913 [PubMed - indexed for MEDLINE]Related articles

Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients.

Takeuchi M, Makita Z, Yanagisawa K, Kameda Y, Koike T.

Mol Med. 1999 Jun;5(6):393-405.PMID: 10415164 [PubMed - indexed for MEDLINE]Related articlesFree article

Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.

Basta G, Sironi AM, Lazzerini G, Del Turco S, Buzzigoli E, Casolaro A, Natali A, Ferrannini E, Gastaldelli A.

J Clin Endocrinol Metab. 2006 Nov;91(11):4628-34. Epub 2006 Aug 22.PMID: 16926247 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.

Busch M, Franke S, Wolf G, Rohde RD, Stein G; Collaborative Study Group.

Nephron Clin Pract. 2008;108(4):c291-7. Epub 2008 Apr 24.PMID: 18434751 [PubMed - indexed for MEDLINE]Related articles

Serum tissue inhibitors of metalloproteinases 1 (TIMP-1) and carotid atherosclerosis and aortic arterial stiffness.

Zureik M, Beaudeux JL, Courbon D, Bénétos A, Ducimetière P.

J Hypertens. 2005 Dec;23(12):2263-8.PMID: 16269968 [PubMed - indexed for MEDLINE]Related articles

Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.

Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Nakatani Y, Ohtoshi K, Hayaishi-Okano R, Kosugi K, Hori M, Yamasaki Y.

Diabetes Care. 2005 Nov;28(11):2716-21.PMID: 16249545 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.

den Hollander NC, Mulder DJ, Graaff R, Thorpe SR, Baynes JW, Smit GP, Smit AJ.

J Inherit Metab Dis. 2007 Nov;30(6):916-23. Epub 2007 Jun 14.PMID: 17570077 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of 12-month valsartan therapy on glycation and oxidative stress markers in type 2 diabetic subjects with hypertension.

Komiya N, Hirose H, Saisho Y, Saito I, Itoh H.

Int Heart J. 2008 Nov;49(6):681-9.PMID: 19075484 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.

Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, Horiuchi S, Itabe H, Takano T.

Atherosclerosis. 1998 Nov;141(1):61-75.PMID: 9863539 [PubMed - indexed for MEDLINE]Related articles

Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.

Hamada Y, Nakamura J, Naruse K, Komori T, Kato K, Kasuya Y, Nagai R, Horiuchi S, Hotta N.

Diabetes Care. 2000 Oct;23(10):1539-44.PMID: 11023149 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end products and mortality in hemodialysis patients.

Schwedler SB, Metzger T, Schinzel R, Wanner C.

Kidney Int. 2002 Jul;62(1):301-10.PMID: 12081592 [PubMed - indexed for MEDLINE]Related articlesFree article

Echogenic carotid plaques are associated with aortic arterial stiffness in subjects with subclinical carotid atherosclerosis.

Zureik M, Bureau JM, Temmar M, Adamopoulos C, Courbon D, Bean K, Touboul PJ, Benetos A, Ducimetière P.

Hypertension. 2003 Mar;41(3):519-27. Epub 2003 Feb 10.PMID: 12623953 [PubMed - indexed for MEDLINE]Related articlesFree article

N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis.

Motomiya Y, Oyama N, Iwamoto H, Uchimura T, Maruyama I.

Kidney Int. 1998 Oct;54(4):1357-66.PMID: 9767556 [PubMed - indexed for MEDLINE]Related articlesFree article

Noninvasive measurement of carotid extra-media thickness: associations with cardiovascular risk factors and intima-media thickness.

Skilton MR, Sérusclat A, Sethu AH, Brun S, Bernard S, Balkau B, Moulin P, Bonnet F.

JACC Cardiovasc Imaging. 2009 Feb;2(2):176-82.PMID: 19356553 [PubMed - indexed for MEDLINE]Related articles